Rhone Ma Holdings Bhd is on track to deliver a compound annual growth rate (CAGR) of 14% in core earnings over the two-year period spanning financial years 2026 to 2028, according to a new research note from Mercury Securities.
The brokerage’s projection underscores growing confidence in the Kuala Lumpur-listed animal health solutions provider’s ability to sustain momentum in a competitive sector.
The forecast covers the period from FY26 through FY28, positioning Rhone Ma as a stock with double-digit earnings expansion potential in the near term.
Mercury Securities’ analysis highlights the company’s operational resilience and market positioning as key drivers behind the upgraded outlook.
For investors tracking Malaysian mid-cap equities, the note adds Rhone Ma to a shortlist of value stocks identified for rapid growth through 2028, alongside other sector peers receiving positive revisions from local brokerages.
The update comes as regional analysts increasingly focus on companies with clear visibility into earnings growth amid broader macroeconomic uncertainty.